— Know what they know.
Not Investment Advice
Also trades as: 688236.SS (SHH) · $vol 5M

1858.HK HKSE

Beijing Chunlizhengda Medical Instruments Co., Ltd.
1W: -4.0% 1M: -10.1% 3M: -18.2% YTD: -46.6% 1Y: -55.0% 3Y: -45.0% 5Y: -61.6%
HK$7.48 ($0.95)
-0.35 (-4.53%)
 
Weekly Expected Move ±5.2%
HK$7 HK$7 HK$7 HK$8 HK$8
HKSE · Healthcare · Medical - Devices · Tech Score Sell · Power 37 · HK$4.5B mcap · 579M float · 0.129% daily turnover
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market CapHK$4.5B ($567.5M)
52W Range7.44-20.82
Volume102,750
Avg Volume749,859
Beta-0.25
DividendHK$0.40
Analyst Ratings
No analyst coverage
Company Info
CEOChunsheng Shi
Employees841
SectorHealthcare
IndustryMedical - Devices
IPO Date2015-03-11
Websiteclzd.com
No. 10 Xinmi Xi Er Road
Beijing, BE 100021
CN
+86 10 5165 1111
About Beijing Chunlizhengda Medical Instruments Co., Ltd.

Beijing Chunlizhengda Medical Instruments Co., Ltd. functions as a prominent entity within the orthopedic medical device industry, dedicated to the development, manufacturing, and distribution of surgical implants, instruments, and associated medical supplies throughout the People's Republic of China. Its core product range features implantable orthopedic solutions, specifically comprising joint prostheses and spinal treatment products. The company predominantly distributes its merchandise via an expansive network of distributors, through original design manufacturing (ODM) and original equipment manufacturing (OEM) partnerships under the 'Chunli' label, and by direct sales to healthcare institutions. Beyond its domestic operations, the firm also engages in exporting its products to various countries globally. Established in 1998, its corporate headquarters are situated in Beijing, China.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms